Hydrolytic Lysosomal Glucocerebroside-specific Enzyme
- Name
- Hydrolytic Lysosomal Glucocerebroside-specific Enzyme
- Accession Number
- DBCAT003262
- Description
Not Available
- Drugs
Drug Drug Description Imiglucerase A form of recombinant human beta-glucocerebrosidase enzyme used to replace the deficient endogenous enzyme in the treatment of Gaucher disease. Alglucerase A form of recombinant beta-glucocerebrosidase enzyme used to replace the deficient endogenous enzyme in the treatment of Gaucher disease. Velaglucerase alfa An enzyme replacement therapy used for the long-term treatment of for pediatric and adult patients with type 1 Gaucher disease. Taliglucerase alfa A hydrolytic lysosomal glucocerebroside specific enzyme, used for long term enzyme replacement therapy in patients with Type 1 Gaucher disease. - Drugs & Drug Targets
Drug Target Type Imiglucerase Glucocerebroside target Alglucerase Glucocerebroside target Velaglucerase alfa Glucosylceramidase target Taliglucerase alfa Glucocerebroside target